ZBH Insider Trading

Insider Ownership Percentage: 0.95%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $150,649.20

Zimmer Biomet Insider Trading History Chart

This chart shows the insider buying and selling history at Zimmer Biomet by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$151ksoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$4M-$2M$0$2M$4MTotal Insider BuyingTotal Insider Selling

Zimmer Biomet Share Price & Price History

Current Price: $110.10
Price Change: Price Increase of +2.532 (2.35%)
As of 03/14/2025 04:59 PM ET

This chart shows the closing price history over time for ZBH up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
AprMayJunJulAugSepOctNovDecJanFebMar$110.10Closing price on 03/15/25:

SEC Filings (Institutional Ownership Changes) for Zimmer Biomet (NYSE:ZBH)

88.89% of Zimmer Biomet stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ZBH by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$1.81Bbought$1.06BsoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$1B$0$1BTotal InflowsTotal Outflows
Zimmer Biomet logo
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Read More on Zimmer Biomet

Today's Range

Now: $110.10
Low: $106.40
High: $110.32

50 Day Range

MA: $105.83
Low: $98.98
High: $112.54

52 Week Range

Now: $110.10
Low: $97.69
High: $133.90

Volume

2,301,092 shs

Average Volume

1,929,614 shs

Market Capitalization

$21.92 billion

P/E Ratio

24.74

Dividend Yield

0.87%

Beta

1.04

Who are the company insiders with the largest holdings of Zimmer Biomet?

Zimmer Biomet's top insider investors include:
  1. Chad F Phipps (VP)
  2. Lori Winkler (SVP)
  3. Robert Hagemann (Director)
  4. Arthur J Higgins (Director)
  5. Michael W Michelson (Director)
  6. Sreelakshmi Kolli (Director)
  7. Betsy J Bernard (Director)
Learn More about top insider investors at Zimmer Biomet.

Who are the major institutional investors of Zimmer Biomet?

Zimmer Biomet's top institutional investors include:
  1. Vanguard Group Inc. — 11.50%
  2. Dodge & Cox — 9.60%
  3. Price T Rowe Associates Inc. MD — 7.41%
  4. American Century Companies Inc. — 2.97%
  5. Geode Capital Management LLC — 2.45%
  6. Primecap Management Co. CA — 2.41%
Learn More about top institutional investors of Zimmer Biomet stock.

Which major investors are selling Zimmer Biomet stock?

In the last quarter, ZBH stock was sold by these institutional investors:
  1. Victory Capital Management Inc.
  2. Boston Partners
  3. Bank of America Corp DE
  4. American Century Companies Inc.
  5. Vanguard Group Inc.
  6. Legal & General Group Plc
  7. Johnson Investment Counsel Inc.
  8. Sequoia Financial Advisors LLC

Which major investors are buying Zimmer Biomet stock?

In the last quarter, ZBH stock was purchased by institutional investors including:
  1. Franklin Resources Inc.
  2. Norges Bank
  3. Dodge & Cox
  4. Nuveen Asset Management LLC
  5. Sound Shore Management Inc. CT
  6. FMR LLC
  7. Freestone Grove Partners LP
  8. Equity Investment Corp
Within the previous year, these company insiders have bought Zimmer Biomet stock:
  1. Chad F Phipps (VP)
  2. Lori Winkler (SVP)
  3. Robert Hagemann (Director)
  4. Arthur J Higgins (Director)
  5. Michael W Michelson (Director)
Learn More investors buying Zimmer Biomet stock.